Moolec Science (MLEC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Moolec Science SA has presented its unaudited interim condensed consolidated financial statements, revealing a total comprehensive loss for the nine months ended March 31, 2024, which is significantly lower than the previous year’s. Key figures include a net loss before income tax of $5,101,080 for the nine months in 2024, compared to a substantial loss of $49,040,852 in the same period of 2023, indicating a notable reduction in losses year-over-year. This financial overview is critical for investors monitoring Moolec Science’s performance and future prospects.
For further insights into MLEC stock, check out TipRanks’ Stock Analysis page.
